Onconetix Enters Amendment To Share Exchange Agreement Regarding Merger With Realbotix; If The Net Cash Is Less Than $12.5M And Parties Proceed With Closing, The Seller Will Own 95% Of The Buyer's Shares
As previously disclosed, on February 11, 2026, Onconetix, Inc., a Delaware corporation ("Onconetix" or "Buyer"), entered into a Share Exchange Agreement (the "Share Exchange Agreement"), by and
Onconetix changed the rules for its merger with Realbotix. If the combined company has less than $12.5 million in cash, the seller gets almost all the ownership instead.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.